Trial NCT02730195

View at ClinicalTrials.gov 
Org. Study IDs: IRB00086670
Secondary IDs: NCI-2016-00248 Winship3121-15

Last trial update was posted on 2019-01-09

MeSH Interventions

Pioglitazone Tyrosine Kinase Inhibitors

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid

Other Conditions

Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Stopping Reasons

N/A

Limitations And Caveats

Study was terminated early due to previous principal investigator leaving institution.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID